Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T

Moderna and China’s CARsgen Therapeutics are collaborating to combine their respective mRNA therapeutic cancer vaccine with a solid tumor CAR T cell therapy, the Chinese biotech announced on Monday.